Cargando…

Usefulness and pitfalls of MAA SPECT/CT in identifying digestive extrahepatic uptake when planning liver radioembolization

PURPOSE: Identifying gastroduodenal uptake of (99m)Tc-macroaggregated albumin (MAA), which is associated with an increased risk of ulcer disease, is a crucial part of the therapeutic management of patients undergoing radioembolization for liver tumours. Given this context, the use of MAA single phot...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lenoir, Laurence, Edeline, Julien, Rolland, Yann, Pracht, Marc, Raoul, Jean-Luc, Ardisson, Valérie, Bourguet, Patrick, Clément, Bruno, Boucher, Eveline, Garin, Etienne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2012
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3326232/ https://www.ncbi.nlm.nih.gov/pubmed/22237844 http://dx.doi.org/10.1007/s00259-011-2033-4

Ejemplares similares

Clinical impact of (99m)Tc-MAA SPECT/CT-based dosimetry in the radioembolization of liver malignancies with (90)Y-loaded microspheres
por: Garin, Etienne, et al.
Publicado: (2015)

Utility of Quantitative (99m)Tc-MAA SPECT/CT for (90)yttrium-Labelled Microsphere Treatment Planning: Calculating Vascularized Hepatic Volume and Dosimetric Approach
por: Garin, Etienne, et al.
Publicado: (2011)

Lobar Hepatocellular Carcinoma with Ipsilateral Portal Vein Tumor Thrombosis Treated with Yttrium-90 Glass Microsphere Radioembolization: Preliminary Results
por: Pracht, M., et al.
Publicado: (2013)

Dosimetric parameters predicting contralateral liver hypertrophy after unilobar radioembolization of hepatocellular carcinoma
por: Palard, Xavier, et al.
Publicado: (2017)

High impact of macroaggregated albumin‐based tumour dose on response and overall survival in hepatocellular carcinoma patients treated with (90)Y‐loaded glass microsphere radioembolization
por: Garin, Etienne, et al.
Publicado: (2016)

Transarterial Radioembolization (TARE) Agents beyond (90)Y-Microspheres
por: Bouvry, C., et al.
Publicado: (2018)

The joint use of (99m)Tc-MAA-SPECT/CT and cone-beam CT optimizes radioembolization planning
por: Rodríguez-Fraile, Macarena, et al.
Publicado: (2021)

(188)Re-SSS Lipiodol Radioembolization in HCC Patients: Results of a Phase 1 Trial (Lip-Re-01 Study)
por: Garin, Etienne, et al.
Publicado: (2023)

The value of (99m)Tc-MAA SPECT/CT for lung shunt estimation in (90)Y radioembolization: a phantom and patient study
por: Allred, Jonathan D., et al.
Publicado: (2018)

Radioembolization with Y-90 Glass Microspheres: Do We Really Need SPECT-CT to Identify Extrahepatic Shunts?
por: Theysohn, Jens M., et al.
Publicado: (2015)

Boosted selective internal radiation therapy with (90)Y-loaded glass microspheres (B-SIRT) for hepatocellular carcinoma patients: a new personalized promising concept
por: Garin, E., et al.
Publicado: (2013)

Correlation of C-arm CT acquired parenchymal blood volume (PBV) with (99m)Tc-macroaggregated albumin (MAA) SPECT/CT for radioembolization work-up
por: Weissinger, Matthias, et al.
Publicado: (2020)

Diagnostic and prognostic value of (99m)Tc-MAA SPECT/CT for treatment planning of (90)Y-resin microsphere radioembolization for hepatocellular carcinoma: comparison with planar image
por: Son, Mai Hong, et al.
Publicado: (2021)

Impact of the dosimetry approach on the resulting (90)Y radioembolization planned absorbed doses based on (99m)Tc-MAA SPECT-CT: is there agreement between dosimetry methods?
por: Morán, Verónica, et al.
Publicado: (2020)

Automated segmentation of lung, liver, and liver tumors from Tc‐99m MAA SPECT/CT images for Y‐90 radioembolization using convolutional neural networks
por: Chaichana, Anucha, et al.
Publicado: (2021)

Factors modulating (99m)Tc‐MAA planar lung dosimetry for (90)Y radioembolization
por: Lopez, Benjamin P., et al.
Publicado: (2022)

Combined quality and dose-volume histograms for assessing the predictive value of (99m)Tc-MAA SPECT/CT simulation for personalizing radioembolization treatment in liver metastatic colorectal cancer
por: Levillain, Hugo, et al.
Publicado: (2020)

Adaptive scan duration in SPECT: Evaluation for radioembolization
por: Dietze, Martijn M. A., et al.
Publicado: (2020)

Erratum: “Factors modulating (99m)Tc‐MAA planar lung dosimetry for (90)Y radioembolization”
Publicado: (2023)

Correction to: Combined quality and dose-volume histograms for assessing the predictive value of (99m)Tc-MAA SPECT/CT simulation for personalizing radioembolization treatment in liver metastatic colorectal cancer
por: Levillain, Hugo, et al.
Publicado: (2021)

Retrospective SPECT/CT dosimetry following transarterial radioembolization
por: Thompson, Briana C., et al.
Publicado: (2021)

Selective Internal Radiation Combined with Chemotherapy Maintains the Quality of Life in Intrahepatic Cholangiocarcinomas
por: Goislard de Monsabert, Camille, et al.
Publicado: (2021)

Extrahepatic transarterial radioembolization to treat fibrolamellar hepatocellular carcinoma: A case report
por: Ljuboja, Damir, et al.
Publicado: (2020)

(90)Y SPECT/CT quantitative study and comparison of uptake with pretreatment (99 m)Tc‐MAA SPECT/CT in radiomicrosphere therapy
por: Debebe, Senait Aknaw, et al.
Publicado: (2019)

Standardizing SPECT/CT dosimetry following radioembolization with yttrium-90 microspheres
por: Kim, S. Peter, et al.
Publicado: (2021)

Advances in SPECT for Optimizing the Liver Tumors Radioembolization Using Yttrium-90 Microspheres
por: Roshan, Hoda Rezaei, et al.
Publicado: (2015)

From summative MAAS Global to formative MAAS 2.0 – a workshop report
por: Stamer, Tjorven, et al.
Publicado: (2023)

Fast technetium‐99m liver SPECT for evaluation of the pretreatment procedure for radioembolization dosimetry
por: van der Velden, Sandra, et al.
Publicado: (2018)

ALBI Score Is a Strong Predictor of Toxicity Following SIRT for Hepatocellular Carcinoma
por: Lescure, Céline, et al.
Publicado: (2021)

Yttrium‐90 Radioembolization for the Treatment of Solitary, Unresectable HCC: The LEGACY Study
por: Salem, Riad, et al.
Publicado: (2021)

Preclinical Evaluation of (68)Ga-MAA from Commercial Available (99m)Tc-MAA Kit
por: Shanehsazzadeh, Saeed, et al.
Publicado: (2017)

Use of C-Arm Cone Beam CT During Hepatic Radioembolization: Protocol Optimization for Extrahepatic Shunting and Parenchymal Enhancement
por: van den Hoven, Andor F., et al.
Publicado: (2015)

The Predictive Value of SPECT/CT imaging in colorectal liver metastases response after (90)Y-radioembolization
por: Piasecki, Piotr, et al.
Publicado: (2018)

Lung perfusion [(99m)Tc]-MAA SPECT/CT to rule out pulmonary embolism in COVID-19 patients with contraindications for iodine contrast
por: Burger, Irene A., et al.
Publicado: (2020)

Technical Solutions to Ensure Safe Yttrium-90 Radioembolization in Patients With Initial Extrahepatic Deposition of (99m)Technetium–Albumin Macroaggregates
por: Barentsz, M. W., et al.
Publicado: (2010)

A purified MAA-based ELISA is a useful tool for determining anti-MAA antibody titer with high sensitivity
por: Shimomoto, Takasumi, et al.
Publicado: (2017)

Distribution, Contents, and Types of Mycosporine-Like Amino Acids (MAAs) in Marine Macroalgae and a Database for MAAs Based on These Characteristics
por: Sun, Yingying, et al.
Publicado: (2020)

Quantitative Comparison of PET and Bremsstrahlung SPECT for Imaging the In Vivo Yttrium-90 Microsphere Distribution after Liver Radioembolization
por: Elschot, Mattijs, et al.
Publicado: (2013)

Personalized predictive lung dosimetry by technetium-99m macroaggregated albumin SPECT/CT for yttrium-90 radioembolization
por: Kao, Yung Hsiang, et al.
Publicado: (2014)

Accuracy of SPECT/CT‐based lung dose calculation for Holmium‐166 hepatic radioembolization before OSEM convergence
por: van Nierop, Bastiaan J., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_epdj861vlbl1r01kbpvfr9qcf0